Importance of receptor expression in the classification of novel ligands at the M2 muscarinic acetylcholine receptor

Br J Pharmacol. 2024 Jul;181(14):2338-2350. doi: 10.1111/bph.16021. Epub 2023 Jan 20.

Abstract

Background and purpose: Affinity-based, selective orthosteric ligands for the muscarinic acetylcholine receptors (mAChRs) are difficult to develop due to high sequence homology across the five subtypes. Selectivity can also be achieved via the selective activation of a particular subtype or signalling pathway. Promisingly, a prior study identified compounds 6A and 7A as functionally selective and Gi biased compounds at the M2 mAChR. Here, we have investigated the activation of individual G protein subfamilies and the downstream signalling profiles of 6A and 7A at the M2 mAChR.

Experimental approach: G protein activation was measured with the TRUPATH assay in M2 mAChR FlpIn CHO cells. Activity in downstream signalling pathways was determined using the cAMP CAMYEL BRET sensor and assay of ERK 1/2 phosphorylation.

Key results: M2 mAChRs coupled to Gɑi1, GɑoA and Gɑs, but not Gɑq, in response to canonical orthosteric agonists. Compounds 6A and 7A did not elicit any G protein activation, cAMP inhibition or stimulation, or ERK 1/2 phosphorylation. Instead, a Schild analysis indicates a competitive, antagonistic interaction of compounds 6A and 7A with ACh in the Gɑi1 activation assay. Overexpression of the M2 mAChR may suggest an expression-dependent activation profile of compounds 6A and 7A.

Conclusions and implications: These data confirm that the M2 mAChR preferentially couples to Gɑi/o and to a lesser extent to Gɑs in response to canonical orthosteric ligands. However, this study was not able to detect Gɑi bias of compounds 6A and 7A, highlighting the importance of cellular background when classifying new ligands.

Linked articles: This article is part of a themed issue Therapeutic Targeting of G Protein-Coupled Receptors: hot topics from the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists 2021 Virtual Annual Scientific Meeting. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v181.14/issuetoc.

Keywords: CAMYEL; TRUPATH; antagonist; muscarinic acetylcholine receptor; partial agonist; signalling bias.

MeSH terms

  • Animals
  • CHO Cells
  • Cricetulus*
  • Cyclic AMP / metabolism
  • GTP-Binding Proteins / metabolism
  • Humans
  • Ligands
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3 / metabolism
  • Muscarinic Agonists / pharmacology
  • Phosphorylation
  • Receptor, Muscarinic M2* / agonists
  • Receptor, Muscarinic M2* / antagonists & inhibitors
  • Receptor, Muscarinic M2* / genetics
  • Receptor, Muscarinic M2* / metabolism
  • Signal Transduction / drug effects

Substances

  • Ligands
  • Receptor, Muscarinic M2
  • Mitogen-Activated Protein Kinase 1
  • Muscarinic Agonists
  • Mitogen-Activated Protein Kinase 3
  • GTP-Binding Proteins
  • Cyclic AMP